39 related articles for article (PubMed ID: 7933838)
1. Renal effects of growth hormone in health and in kidney disease.
Haffner D; Grund A; Leifheit-Nestler M
Pediatr Nephrol; 2021 Aug; 36(8):2511-2530. PubMed ID: 34143299
[TBL] [Abstract][Full Text] [Related]
2. The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.
Oh Y
Kidney Res Clin Pract; 2012 Mar; 31(1):26-37. PubMed ID: 26889406
[TBL] [Abstract][Full Text] [Related]
3. Effect of growth hormone on plasminogen activator and inhibitor activity in rat.
Bubber P; Sharma A; Chauhan A; Bansal DD
Indian J Clin Biochem; 2013 Apr; 28(2):193-6. PubMed ID: 24426209
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders.
Kang YJ; Digicaylioglu M; Russo R; Kaul M; Achim CL; Fletcher L; Masliah E; Lipton SA
Ann Neurol; 2010 Sep; 68(3):342-52. PubMed ID: 20818790
[TBL] [Abstract][Full Text] [Related]
5. Disturbed synthesis of insulinlike growth factor I and its binding proteins may influence renal function changes in liver cirrhosis.
Fernández-Rodriguez CM; Prada I; Andrade A; Moreiras M; Guitián R; Aller R; Lledó JL; Cacho G; Quiroga J; Prieto J
Dig Dis Sci; 2001 Jun; 46(6):1313-20. PubMed ID: 11414310
[TBL] [Abstract][Full Text] [Related]
6. Renoprotective therapy in patients with nondiabetic nephropathies.
Pisoni R; Ruggenenti P; Remuzzi G
Drugs; 2001; 61(6):733-45. PubMed ID: 11398906
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone.
Mauras N; Haymond MW
Pediatr Nephrol; 1996 Jun; 10(3):318-23. PubMed ID: 8792396
[TBL] [Abstract][Full Text] [Related]
8. What are the clinical uses of insulin-like growth factor-I in acute and chronic renal failure?
Hammerman MR
Pediatr Nephrol; 1994 Oct; 8(5):544. PubMed ID: 7818998
[No Abstract] [Full Text] [Related]
9. Influence of growth hormone and insulin-like growth factor-I on kidney function and kidney growth.
Ritz E; Tönshoff B; Worgall S; Kovacs G; Mehls O
Pediatr Nephrol; 1991 Jul; 5(4):509-12. PubMed ID: 1911130
[TBL] [Abstract][Full Text] [Related]
10. The use of growth factors to increase glomerular filtration rate in chronic renal failure patients.
Miller SB; Rabkin R
Curr Opin Nephrol Hypertens; 1997 Jul; 6(4):401-4. PubMed ID: 9263692
[TBL] [Abstract][Full Text] [Related]
11. Effects of IGF-I on renal function in end-stage chronic renal failure.
Miller SB; Moulton M; O'Shea M; Hammerman MR
Kidney Int; 1994 Jul; 46(1):201-7. PubMed ID: 7933838
[TBL] [Abstract][Full Text] [Related]
12. Effects of IGF-I on renal function in patients with chronic renal failure.
O'Shea MH; Miller SB; Hammerman MR
Am J Physiol; 1993 May; 264(5 Pt 2):F917-22. PubMed ID: 8498545
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I treatment to enhance renal function in advanced chronic renal failure.
Fervenza FC; Friedlaender MM; Ike JO; Rabkin R
Ren Fail; 1998 Mar; 20(2):349-56. PubMed ID: 9574462
[TBL] [Abstract][Full Text] [Related]
14. Early experience with extended use of insulin-like growth factor-1 in advanced chronic renal failure.
Ike JO; Fervenza FC; Hoffman AR; Yeh I; Hintz RL; Liu F; Rabkin R
Kidney Int; 1997 Mar; 51(3):840-9. PubMed ID: 9067919
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I improves renal function in patients with end-stage chronic renal failure.
Vijayan A; Franklin SC; Behrend T; Hammerman MR; Miller SB
Am J Physiol; 1999 Apr; 276(4):R929-34. PubMed ID: 10198369
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
